APAC Empty Capsules Market

APAC Empty Capsules Market Size (2023 to 2028)

The size of the Empty Capsules Market in the Asia Pacific region is predicted to grow USD 662.80 million by 2028 and USD 374.41 million in 2023, registering a CAGR of 12.1% during the forecast period.

The increase in the elderly population, the growing need for empty capsules in the pharmaceutical, functional foods, and cosmetics industries, and increased preference of consumers for refined capsules are a few of the primary drivers of the Asia Pacific market growth. The rapid degradation rate, which speeds up absorption and uses a tasteless, odorless gelatin covering, is why most customers choose capsules. These pills are delicious. Most nutraceuticals and Cosmeceuticals, such as cod liver oil capsules and Cosmo Pod capsules, are favored in capsule form. The empty capsules are available in a variety of tastes and colors. Due to various benefits such as better satisfactoriness and a faster absorption rate, capsules are the most preferred strong measurement structures in the drug industry to treat a variety of chronic and irresistible infections, which represents the greatest demand for these empty capsules in the drug industry. The proliferation of the pharmaceutical industry in the region, government initiatives to develop medical infrastructure, including the pharmaceutical manufacturing industry, increased demand for nutrients and cosmetics due to increased awareness of the welfare trends of these empty capsules, and other factors all contribute to overall market growth.

The rise of the APAC Empty capsules market is further attributed to the rising popularity of nutritional supplements to enhance immunity. Despite this, rapid advancements in capsule delivery technologies and continuous research for the creation of empty capsules with government backing may provide more opportunities for the empty capsules market to expand. Overall, there is a clear growth in demand for soft gelatin capsules in this region, and it would be prudent to discover a strategy to expand in this market. A rise in the attractiveness of capsules over alternative drug delivery forms, as well as an increase in strategic alliances between empty capsule providers and gelatin producers, is driving market expansion. In addition, as the elderly population grows, the need for various treatment medicines and nutritional supplements to improve health outcomes grows. Furthermore, the increasing popularity of dietary supplements is boosting market growth in the coming years.

The expansion of the APAC empty capsules market is restricted by growing commodity prices and cultural and religious concerns about using capsules containing inactive components of animal origin, such as pork capsules and bovine gelatin envelopes. The market growth is likely to be limited by ethical concerns, price volatility of gelatinous raw materials, and stringent regulations in the pharmaceutical sector.

This research report on the APAC Empty Capsules Market has been segmented and sub-segmented into the following categories:

By Product:

• Gelatin Capsules
• Non-Gelatin Capsules

By Therapeutic Application:

• Antibiotic And Antibacterial Drugs
• Vitamins And Dietary Supplements
• Antacid And Antiflatulent Preparations
• Antianemic Preparations
• Anti-Inflammatory Drugs
• Cardiovascular Therapy Drugs
• Cough And Cold Preparations
• Other Therapeutic Application

By End User:

• Pharmaceutical Industry
• Nutraceutical Industry
• Cosmetics Industry
• Research Laboratories

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, Asia-Pacific is estimated to be the fastest-growing region due to increasing government support and increasing demand for nutraceuticals and cosmeceuticals. Within Asia-Pacific, India is the fastest-growing region due to its high population base and increasing healthcare expenditure. Empty capsules are in more demand due to the rising emphasis on better pharmaceutical goods and generics. Several reasons are likely to fuel APAC's impressive growth, including the region's considerable expansion in pharmaceutical production in recent years. Due to its large population, growing geriatric population, and evolving healthcare industry, India is the most attractive market in Asia. Furthermore, a rising number of manufacturers are looking into the opportunities given by emerging countries, contributing to the Asia-Pacific region's highest growth rate throughout the forecast period. Asia Pacific (APAC) consumers are emphasizing the need for modern healthcare services and capsule-based medicines. Furthermore, the pharmaceutical sector in the area is rapidly developing, particularly in China and India. These factors are important drivers for the APAC empty capsules market, which is expected to grow almost thrice over the next decade. The proliferation of pharmaceutical industries in this region, as well as favorable government initiatives about the development of healthcare infrastructure, which includes pharmaceutical manufacturing industries, growing demand for nutraceuticals and cosmeceutical as people become more conscious of wellness trends and adopt more fitness-oriented lifestyles, have all contributed to the overall growth of the Asia Pacific empty capsules market.

KEY MARKET PLAYERS:

A few of the notable companies in the APAC Empty Capsules Market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd, and Sunil Healthcare Limited.